Invention Application
- Patent Title: IMMUNE REPERTOIRE BIOMARKERS FOR PREDICTION OF TREATMENT RESPONSE IN AUTOIMMUNE DISEASE
-
Application No.: US17889654Application Date: 2022-08-17
-
Publication No.: US20230131285A1Publication Date: 2023-04-27
- Inventor: Shrutii SARDA , Geoffrey LOWMAN
- Applicant: Life Technologies Corporation
- Applicant Address: US CA Carlsbad
- Assignee: Life Technologies Corporation
- Current Assignee: Life Technologies Corporation
- Current Assignee Address: US CA Carlsbad
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883

Abstract:
Prediction of a clinical response to a therapy of a subject with an autoimmune disease based on B cell immune repertoire may include determining a plurality of clone frequencies in a biological sample from the subject, wherein the clone frequencies include: IgM, IgD, IgG3, IgG4, IgA, IgM with first somatic hypermutation (SHM) level, IgG1 with second SHM level. A plurality of decision criteria may be applied to features including the plurality of clone frequencies. Each decision criterion applies at least one threshold to a feature, wherein the plurality of decision criteria provides a plurality of output values. The plurality of output values may be summed and a sigmoid transformation may be applied to the summed value to form a prediction value. The prediction value may be compared to a final threshold to identify the subject as a likely responder or non-responder to an autoimmune disease therapy.
Information query